Advanced Search


Study ID Status Title Patient Level Data
116628 Completed A Single Center Phase 1 Double Blind Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects Study Listed on
116640 Completed Development of read-outs to detect and characterise the early and adaptive immune responses in healthy, hepatitis B virus naive adults vaccinated with the hepatitis B surface antigen in combination with a GSK Biologicals’ Adjuvant System
116647 Completed An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ Non-typeable Haemophilus influenzae (NTHi) investigational vaccine (GSK2838497A) in current and former smokers
116663 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix/Influsplit SSW 2012/2013 in people aged 18 years and above
116664 Completed Immunogenicity and safety study of GSK Biologicals’ Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral® (2012/2013 Season) in adults aged 18 years and older Study Listed on
116666 Completed An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666) Study Listed on
116669 Completed RLV116669, A Preference Study of Device Attributes Between Two Placebo Dry Powder inhalers; ELLIPTA and DISKUS, in Adult Subjects with Chronic Obstructive Pulmonary Disease
116678 Completed A Randomised, Double-blind (Sponsor Unblinded), Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of GSK2269557 Administered in Addition to Standard of Care in Adult Subjects Diagnosed With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
116679 Completed A multi-centre, randomised, double-blind, placebo-controlled, dose ranging study to evaluate the safety and efficacy of GSK2586184 in patients with chronic plaque psoriasis Study Listed on
116681 Completed A Phase I, Randomized, Single-Blind, Three-Period Cross-Over, Placebo-Controlled, Single Oral Dose, Dose-Escalation (Part 1), Fixed Sequence, and Repeat Dose (Part 2) Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of losmapimod in Healthy Japanese Subjects. Study Listed on
116682 Recruiting Epidemiology study of malaria transmission intensity in sub-Saharan Africa
116684 Active, Not Recruiting PGX6115: Genetic Effects on Different eltrombopag Exposure between Asians and Whites
116689 Completed An integrated review to evaluate dose response of umeclidinium (GSK573719) administered once or twice daily in Subjects with COPD
116696 Completed Prevalence of patients infected with CCR5-tropic HIV-1 in Korea
116697 Completed Open-label study to evaluate the safety and immunogenicity of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults aged 50 years or older Study Listed on
116698 Completed A Single-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers Study Listed on
116702 Terminated A First Time in Human Study Exploring Preliminary Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2618960 in Healthy Volunteers and Patients with Relapsing Remitting Multiple Sclerosis Study Listed on
116704 Completed A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections Study Listed on
116705 Relinquished Immunogenicity, safety and reactogenicity study of GSK Biologicals’ meningococcal conjugate vaccine (GSK134612) when co-administered with Boostrix® in healthy adolescents and young adults between 11 and 25 years of age
116706 Active, Not Recruiting Pooled analysis of the assessment of the association of lung function improvements on COPD related exacerbations and other endpoints
116707 Terminated A post-marketing surveillance study of Duodart® (Dutasteride/Tamsulosin) in the treatment of Filipino patients with Benign Prostatic Hyperplasia (BPH)
116711 Completed A randomised, placebo-controlled, double-blind, repeat dose escalation study with GSK2126458 in patients with Idiopathic Pulmonary Fibrosis (IPF)
116713 Completed Effects of Medium-Chain Triglycerides on Cognitive Function in Older Subjects with Age-Related Cognitive Decline
116715 Completed A single-center, randomized, blinded, placebo-controlled two-part study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the Selective Androgen Receptor Modulator (SARM), GSK2849466, in single and repeat doses, with and without food, in healthy male subjects Study Listed on
116717 Completed Evaluating the control of COPD symptoms in patients treated with tiotropium bromide 18mcg once daily alone, ADOAIR 50/250mcg twice daily alone or ADOAIR 50/250mcg plus tiotropium bromide 18mcg



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.